[VIEW] agent=Business Affairs Counsel | scenario_id=71 | rounds=20

--- Round 0 ---
[R0.1] Awards & Festivals Lead (speak, public): To align our festival and awards path with a financially defensible release plan, can we discuss the overall spend guardrails and distribution timing rules that might affect our campaign cadence?
[R0.2] Finance FP&A Manager (speak, public): To ensure we're aligned on a financially defensible release plan, I'd like to share some key financial parameters and gather some additional information. Our ROI greenlight rule requires a projected incremental gross of at least $11,000,000 or 1.4x marketing spend. We've planned an initial P&A of $7,800,000 for 600 screens, including $1,200,000 for prints and digital. The awards campaign budget is capped at $2,600,000 with a $300,000 contingency within that cap. Can you help me understand the key schedule milestones and major rights-cost drivers that might affect our spend curve? Additionally, are there any early-audience quality signals that could impact our investment thesis?
[R0.3] Business Affairs Counsel (speak, public): To ensure we're aligned on a financially defensible release plan, I've shared some key contractual and compliance details previously. We have PVOD allowed 60 days after theatrical and streaming on our partner platform at day 150. Additionally, we need to consider the E&O insurance requirement with a limit of $10,000,000 and a deductible of $50,000. For festival submissions, we need locked materials by July 15, 2026, and our legal review SLA is 5 business days. Can you help me understand if there are any undisclosed commercial side-incentives or tight vendor-payment timing constraints that could complicate approvals?

--- Round 1 ---
[R1.1] Awards & Festivals Lead (speak, public): To ensure we're aligned on a financially defensible release plan, I'd like to provide some additional context on our festival and awards strategy. We're planning a world premiere at either Telluride on August 30, 2026, or TIFF on September 10, 2026, as fallbacks. We've also scheduled 12 guild screenings across LA and NY from October 5 to November 20, 2026. Our awards vendor budget is broken down into $310,000 for consultants and $185,000 for PR retainers, totaling $495,000. The talent has varying capacities for press engagements—our lead actress is available for 8 days, while the director can manage 12 days. For context, a comparable prestige drama campaign last year spent $2.1 million and secured 3 nominations. Can you help me understand if there are any rights or publicity constraints that could force schedule changes, or if there are hidden cash-timing limits or reputational exposures we should be aware of?
[R1.2] Finance FP&A Manager (speak, public): To validate our release-and-campaign plan, I've gathered that we're planning a world premiere at either Telluride or TIFF, with 12 guild screenings scheduled across LA and NY. I've also noted the awards vendor budget breakdown. To further assess our financial defensibility, can you help me understand if there are any sensitive dispute exposures or overall spend guardrails we should be aware of? Additionally, are there any distribution timing rules that might impact our campaign cadence?
[R1.3] Business Affairs Counsel (speak, public): To further assess our release-and-campaign plan, I've gathered that we have PVOD allowed 60 days after theatrical and streaming on our partner platform at day 150. Additionally, we need to consider the E&O insurance requirement and the contracting timeline for submissions. Regarding talent scheduling sensitivities, our lead actress is obligated to participate in up to 10 days of awards-related events at a per diem of $260/day. I'd like to understand if there are any undisclosed commercial side-incentives or tight vendor-payment timing constraints that could complicate approvals. Can you help me understand if there are any other talent scheduling sensitivities or rights constraints that could impact our campaign?

--- Round 2 ---
[R2.1] Awards & Festivals Lead (speak, public): To further assess our release-and-campaign plan, I've gathered that we're aligned on key financial and contractual parameters. However, I still need to understand if there are any hidden cash-timing limits or unresolved reputational exposures that could materially change our risk posture. Can you help me understand if there are any sensitive cash-timing constraints or reputational risks we should be aware of?
[R2.2] Finance FP&A Manager (speak, public): To further assess our release-and-campaign plan, I've gathered that we're aligned on key financial and contractual parameters. I've noted the key schedule milestones, including the world premiere at either Telluride or TIFF, and the 12 guild screenings scheduled across LA and NY. I've also understood the major rights-cost drivers, such as the PVOD and streaming windowing details. To validate our plan, can you help me understand if there are any sensitive dispute exposures or tight vendor-payment timing constraints that could complicate our financial defensibility?
[R2.3] Business Affairs Counsel (speak, public): To further assess our release-and-campaign plan, I've gathered that we have PVOD allowed 60 days after theatrical and streaming on our partner platform at day 150. Additionally, we need to consider the E&O insurance requirement and the contracting timeline for submissions. Regarding talent scheduling sensitivities, our lead actress is obligated to participate in up to 10 days of awards-related events at a per diem of $260/day. I've also shared our guild requirements for Q&A events, which include a SAG-AFTRA talkback rate of $745/day with a minimum call of 4 hours. I'd like to understand if there are any undisclosed commercial side-incentives or tight vendor-payment timing constraints that could complicate approvals. Can you help me understand if there are any other talent scheduling sensitivities or rights constraints that could impact our campaign?

--- Round 3 ---
[R3.1] Awards & Festivals Lead (speak, public): To further assess our release-and-campaign plan, I've gathered that we're aligned on key financial and contractual parameters. However, I still need to understand if there are any hidden cash-timing limits or unresolved reputational exposures that could materially change our risk posture. Can you help me understand if there are any sensitive cash-timing constraints or reputational risks we should be aware of?
[R3.2] Finance FP&A Manager (speak, public): To validate our release-and-campaign plan, I've gathered that we're aligned on key financial and contractual parameters. I've noted the key schedule milestones, including the world premiere at either Telluride or TIFF, and the 12 guild screenings scheduled across LA and NY. I've also understood the major rights-cost drivers, such as the PVOD and streaming windowing details. To further assess our financial defensibility, can you help me understand if there are any sensitive dispute exposures or tight vendor-payment timing constraints that could complicate our financial defensibility?
[R3.3] Business Affairs Counsel (speak, public): To further assess our release-and-campaign plan, I've gathered that we have PVOD allowed 60 days after theatrical and streaming on our partner platform at day 150. Additionally, we need to consider the E&O insurance requirement and the contracting timeline for submissions. Regarding talent scheduling sensitivities, our lead actress is obligated to participate in up to 10 days of awards-related events at a per diem of $260/day. I've also shared our guild requirements for Q&A events, which include a SAG-AFTRA talkback rate of $745/day with a minimum call of 4 hours. I'd like to understand if there are any undisclosed commercial side-incentives or tight vendor-payment timing constraints that could complicate approvals. Can you help me understand if there are any other talent scheduling sensitivities or rights constraints that could impact our campaign? On a related note, our music licensing status is that we have 3 needle-drop cues, with 2 cleared at $45,000 each and 1 pending with a quote of $120,000.

--- Round 4 ---
[R4.1] Awards & Festivals Lead (speak, public): To further assess our release-and-campaign plan, I've gathered that we're aligned on key financial and contractual parameters. However, I still need to understand if there are any hidden cash-timing limits or unresolved reputational exposures that could materially change our risk posture. Can you help me understand if there are any sensitive cash-timing constraints or reputational risks we should be aware of?
[R4.2] Finance FP&A Manager (speak, public): To validate our release-and-campaign plan, I've gathered that we're aligned on key financial and contractual parameters. I've noted the key schedule milestones, including the world premiere at either Telluride or TIFF, and the 12 guild screenings scheduled across LA and NY. I've also understood the major rights-cost drivers, such as the PVOD and streaming windowing details. To further assess our financial defensibility, can you help me understand if there are any sensitive dispute exposures or tight vendor-payment timing constraints that could complicate our financial defensibility?
[R4.3] Business Affairs Counsel (speak, public): To validate our release-and-campaign plan, I've gathered that we have PVOD allowed 60 days after theatrical and streaming on our partner platform at day 150. Additionally, we need to consider the E&O insurance requirement and the contracting timeline for submissions. Regarding talent scheduling sensitivities, our lead actress is obligated to participate in up to 10 days of awards-related events at a per diem of $260/day. I've also shared our guild requirements for Q&A events, which include a SAG-AFTRA talkback rate of $745/day with a minimum call of 4 hours. Our music licensing status is that we have 3 needle-drop cues, with 2 cleared at $45,000 each and 1 pending with a quote of $120,000. I'd like to understand if there are any undisclosed commercial side-incentives or tight vendor-payment timing constraints that could complicate approvals. Can you help me understand if there are any other talent scheduling sensitivities or rights constraints that could impact our campaign?

--- Round 5 ---
[R5.1] Awards & Festivals Lead (speak, public): To further assess our release-and-campaign plan, I've gathered that we're aligned on key financial and contractual parameters. However, I still need to understand if there are any hidden cash-timing limits or unresolved reputational exposures that could materially change our risk posture. Can you help me understand if there are any sensitive cash-timing constraints or reputational risks we should be aware of?
[R5.2] Finance FP&A Manager (speak, public): To validate our release-and-campaign plan, I've gathered that we're aligned on key financial and contractual parameters. I've noted the key schedule milestones, including the world premiere at either Telluride or TIFF, and the 12 guild screenings scheduled across LA and NY. I've also understood the major rights-cost drivers, such as the PVOD and streaming windowing details. To further assess our financial defensibility, can you help me understand if there are any sensitive dispute exposures or tight vendor-payment timing constraints that could complicate our financial defensibility?
[R5.3] Business Affairs Counsel (speak, public): To validate our release-and-campaign plan, I've gathered that we have PVOD allowed 60 days after theatrical and streaming on our partner platform at day 150. Additionally, we need to consider the E&O insurance requirement and the contracting timeline for submissions. Regarding talent scheduling sensitivities, our lead actress is obligated to participate in up to 10 days of awards-related events at a per diem of $260/day. I've also shared our guild requirements for Q&A events, which include a SAG-AFTRA talkback rate of $745/day with a minimum call of 4 hours. Our music licensing status is that we have 3 needle-drop cues, with 2 cleared at $45,000 each and 1 pending with a quote of $120,000. I'd like to understand if there are any undisclosed commercial side-incentives or tight vendor-payment timing constraints that could complicate approvals. Can you help me understand if there are any other talent scheduling sensitivities or rights constraints that could impact our campaign?

--- Round 6 ---
[R6.1] Awards & Festivals Lead (speak, public): To further assess our release-and-campaign plan, I've gathered that we're aligned on key financial and contractual parameters. However, I still need to understand if there are any hidden cash-timing limits or unresolved reputational exposures that could materially change our risk posture. Can you help me understand if there are any sensitive cash-timing constraints or reputational risks we should be aware of?
[R6.2] Finance FP&A Manager (speak, public): To validate our release-and-campaign plan, I've gathered that we're aligned on key financial and contractual parameters. I've noted the key schedule milestones, including the world premiere at either Telluride or TIFF, and the 12 guild screenings scheduled across LA and NY. I've also understood the major rights-cost drivers, such as the PVOD and streaming windowing details. To further assess our financial defensibility, can you help me understand if there are any sensitive dispute exposures or tight vendor-payment timing constraints that could complicate our financial defensibility?
[R6.3] Business Affairs Counsel (speak, public): To validate our release-and-campaign plan, I've gathered that we have PVOD allowed 60 days after theatrical and streaming on our partner platform at day 150. Additionally, we need to consider the E&O insurance requirement and the contracting timeline for submissions. Regarding talent scheduling sensitivities, our lead actress is obligated to participate in up to 10 days of awards-related events at a per diem of $260/day. I've also shared our guild requirements for Q&A events, which include a SAG-AFTRA talkback rate of $745/day with a minimum call of 4 hours. Our music licensing status is that we have 3 needle-drop cues, with 2 cleared at $45,000 each and 1 pending with a quote of $120,000. I'd like to understand if there are any undisclosed commercial side-incentives or tight vendor-payment timing constraints that could complicate approvals. Can you help me understand if there are any other talent scheduling sensitivities or rights constraints that could impact our campaign?

--- Round 7 ---
[R7.1] Awards & Festivals Lead (speak, public): To further assess our release-and-campaign plan, I've gathered that we're aligned on key financial and contractual parameters. However, I still need to understand if there are any hidden cash-timing limits or unresolved reputational exposures that could materially change our risk posture. Can you help me understand if there are any sensitive cash-timing constraints or reputational risks we should be aware of?
[R7.2] Finance FP&A Manager (speak, public): To validate our release-and-campaign plan, I've gathered that we're aligned on key financial and contractual parameters. I've noted the key schedule milestones, including the world premiere at either Telluride or TIFF, and the 12 guild screenings scheduled across LA and NY. I've also understood the major rights-cost drivers, such as the PVOD and streaming windowing details. To further assess our financial defensibility, can you help me understand if there are any sensitive dispute exposures or tight vendor-payment timing constraints that could complicate our financial defensibility?
[R7.3] Business Affairs Counsel (speak, public): To validate our release-and-campaign plan, I've gathered that we have PVOD allowed 60 days after theatrical and streaming on our partner platform at day 150. Additionally, we need to consider the E&O insurance requirement and the contracting timeline for submissions. Regarding talent scheduling sensitivities, our lead actress is obligated to participate in up to 10 days of awards-related events at a per diem of $260/day. I've also shared our guild requirements for Q&A events, which include a SAG-AFTRA talkback rate of $745/day with a minimum call of 4 hours. Our music licensing status is that we have 3 needle-drop cues, with 2 cleared at $45,000 each and 1 pending with a quote of $120,000. I'd like to understand if there are any undisclosed commercial side-incentives or tight vendor-payment timing constraints that could complicate approvals. Can you help me understand if there are any other talent scheduling sensitivities or rights constraints that could impact our campaign?

--- Round 8 ---
[R8.1] Awards & Festivals Lead (speak, public): To further assess our release-and-campaign plan, I've gathered that we're aligned on key financial and contractual parameters. However, I still need to understand if there are any hidden cash-timing limits or unresolved reputational exposures that could materially change our risk posture. Can you help me understand if there are any sensitive cash-timing constraints or reputational risks we should be aware of?
[R8.2] Finance FP&A Manager (speak, public): To validate our release-and-campaign plan, I've gathered that we're aligned on key financial and contractual parameters. I've noted the key schedule milestones, including the world premiere at either Telluride or TIFF, and the 12 guild screenings scheduled across LA and NY. I've also understood the major rights-cost drivers, such as the PVOD and streaming windowing details. To further assess our financial defensibility, can you help me understand if there are any sensitive dispute exposures or tight vendor-payment timing constraints that could complicate our financial defensibility?
[R8.3] Business Affairs Counsel (speak, public): To validate our release-and-campaign plan, I've gathered that we have PVOD allowed 60 days after theatrical and streaming on our partner platform at day 150. Additionally, we need to consider the E&O insurance requirement and the contracting timeline for submissions. Regarding talent scheduling sensitivities, our lead actress is obligated to participate in up to 10 days of awards-related events at a per diem of $260/day. I've also shared our guild requirements for Q&A events, which include a SAG-AFTRA talkback rate of $745/day with a minimum call of 4 hours. Our music licensing status is that we have 3 needle-drop cues, with 2 cleared at $45,000 each and 1 pending with a quote of $120,000. I'd like to understand if there are any undisclosed commercial side-incentives or tight vendor-payment timing constraints that could complicate approvals. Can you help me understand if there are any other talent scheduling sensitivities or rights constraints that could impact our campaign?

--- Round 9 ---
[R9.1] Awards & Festivals Lead (speak, public): To further assess our release-and-campaign plan, I've gathered that we're aligned on key financial and contractual parameters. However, I still need to understand if there are any hidden cash-timing limits or unresolved reputational exposures that could materially change our risk posture. Can you help me understand if there are any sensitive cash-timing constraints or reputational risks we should be aware of?
[R9.2] Finance FP&A Manager (speak, public): To validate our release-and-campaign plan, I've gathered that we're aligned on key financial and contractual parameters. I've noted the key schedule milestones, including the world premiere at either Telluride or TIFF, and the 12 guild screenings scheduled across LA and NY. I've also understood the major rights-cost drivers, such as the PVOD and streaming windowing details. To further assess our financial defensibility, can you help me understand if there are any sensitive dispute exposures or tight vendor-payment timing constraints that could complicate our financial defensibility?
[R9.3] Business Affairs Counsel (leave, public): 

--- Round 10 ---
[R10.1] Awards & Festivals Lead (speak, public): To further assess our release-and-campaign plan, I've gathered that we're aligned on key financial and contractual parameters. However, I still need to understand if there are any hidden cash-timing limits or unresolved reputational exposures that could materially change our risk posture. Can you help me understand if there are any sensitive cash-timing constraints or reputational risks we should be aware of?
[R10.2] Finance FP&A Manager (speak, public): To validate our release-and-campaign plan, I've gathered that we're aligned on key financial and contractual parameters. I've noted the key schedule milestones, including the world premiere at either Telluride or TIFF, and the 12 guild screenings scheduled across LA and NY. I've also understood the major rights-cost drivers, such as the PVOD and streaming windowing details. To further assess our financial defensibility, can you help me understand if there are any sensitive dispute exposures or tight vendor-payment timing constraints that could complicate our financial defensibility?
[R10.3] Business Affairs Counsel (leave, public): 

--- Round 11 ---
[R11.3] Business Affairs Counsel (leave, public): 

--- Round 12 ---
[R12.1] Awards & Festivals Lead (leave, public): 
[R12.2] Finance FP&A Manager (leave, public): 
[R12.3] Business Affairs Counsel (leave, public): 

--- Round 13 ---
[R13.1] Awards & Festivals Lead (leave, public): 
[R13.2] Finance FP&A Manager (leave, public): 
[R13.3] Business Affairs Counsel (leave, public): 

--- Round 14 ---
[R14.1] Awards & Festivals Lead (leave, public): 
[R14.2] Finance FP&A Manager (leave, public): 
[R14.3] Business Affairs Counsel (leave, public): 

--- Round 15 ---
[R15.1] Awards & Festivals Lead (leave, public): 
[R15.2] Finance FP&A Manager (leave, public): 
[R15.3] Business Affairs Counsel (leave, public): 

--- Round 16 ---
[R16.1] Awards & Festivals Lead (leave, public): 
[R16.2] Finance FP&A Manager (leave, public): 
[R16.3] Business Affairs Counsel (leave, public): 

--- Round 17 ---
[R17.1] Awards & Festivals Lead (leave, public): 
[R17.2] Finance FP&A Manager (leave, public): 
[R17.3] Business Affairs Counsel (leave, public): 

--- Round 18 ---
[R18.1] Awards & Festivals Lead (leave, public): 
[R18.2] Finance FP&A Manager (leave, public): 
[R18.3] Business Affairs Counsel (leave, public): 

--- Round 19 ---
[R19.1] Awards & Festivals Lead (leave, public): 
[R19.2] Finance FP&A Manager (leave, public): 
[R19.3] Business Affairs Counsel (leave, public): 

